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ess: m.broeders@zonneSummary Objective: The Methacholine concentration at which a 20% decrease of
the forced expiratory volume in 1 s (PC20_FEV1) or a 40% increase in airway
resistance (PC40_Rrs6) occur are accepted indicators for airway hyperresponsive-
ness. We hypothesised that the level of detection of bronchial hyperresponsiveness
will differ between the two methods.
Methods: The response to Methacholine was assessed by forced oscillation
technique (FOT) and spirometry in 20 stable hyperresponsive asthmatics. The effects
of repeated lung function measurements on respiratory muscle fatigue were
measured from maximal inspiratory mouth pressure (MIP). After each dose, patients
scored their perception of dyspnoea on a BORG scale. Differences in patient’s burden
were measured by comparing the BORG-score at PC40_Rrs6 (BORG-PC40_Rrs6) and
at PC20_FEV1 (BORG-PC20_FEV1). Reproducibility was also evaluated.
Results: The PC20_FEV1-values were 2.2 (0.4) doubling dose higher as compared
to the PC40_Rrs6 (Po0.001). The mean BORG-score at PC40_Rrs6 was 1.7 points
lower as compared to the BORG-score at PC20_FEV1 (Po0.001). The difference
(mean(SD)) between the PC20_FEV1 of measurement 1 and 2 was 0.1 (1.4) doubling
dose, and 0.3 (2.7) doubling dose for PC40_Rrs6. The MIP after Methacholine
provocation was 1.0(0.2) kPa lower as compared to the MIP before the challenge test
(Po0.001), suggesting respiratory muscle fatigue.
Conclusion: Measuring PC40_Rrs6 shortens the challenge test and lowers the
concentrations of bronchoconstrictor agents as compared to measurements of
PC20_FEV1. The FOT-method was less strenuous for patients. In spite of the fact thatElsevier Ltd. All rights reserved.
68 59911; fax: +31 24 68 59290.
t.nl (M.E.A.C. Broeders).
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acceptable at a mean of 0.3 doubling dose. The respiratory muscle strength was
deteriorated after the challenge test.
& 2005 Elsevier Ltd. All rights reserved.Introduction
The use of a Histamine- or Methacholine challenge
test is well established to quantify airway hyperre-
sponsiveness. Furthermore, these tests can be
helpful to compare the protective effects of
bronchodilators and the relative protective efficacy
of inhalation devices.1
The change in the forced expiratory volume in 1 s
(FEV1) is often used to assess the effect of inhaled
bronchoconstrictive agents. Airway hyperrespon-
siveness is usually defined as the provocative
concentration of Histamine or Methacholine that
induces a 20% fall in FEV1 (PC20_FEV1).
2 Maximal
inspirations and forced expirations require full co-
operation of the patient. The deep inspirations
necessary for forced expiratory manoeuvres might
influence the bronchial tone.3
Induced bronchoconstriction can also be mea-
sured by change of airway impedance using the
forced oscillation technique (FOT). The provocative
dose of Methacholine that induces a 40% increase in
airway resistance at 6Hz (PC40_Rrs6), is an
accepted indicator for airway hyperresponsive-
ness.4,5
In this present study the Methacholine PC20_FEV1
and PC40_Rrs6 were compared. As-mentioned
above, forced expirations require full co-operation
of the patient, which may fatigue the respiratory
muscles. Also the repeated deep inspirations
preceding these manoeuvres might change the
bronchial tone and can induce bronchodilatation.
This might influence the outcome of the bronchial
provocation test. The FOT requires only passive co-
operation, so the bronchial tone will not be
influenced and respiratory muscle fatigue will not
occur. In view of the methodological and physiolo-
gical differences of the tests, we hypothesised that
the level of detection of bronchial hyperrespon-
siveness (PC20_FEV1 and PC40_Rrs6) will differ
between the two methods. The effects of the
repeated lung function measurements on the
respiratory muscle fatigue and subsequently on
parameters of forced expiratory flow were investi-
gated. Patients also scored their perception of
dyspnoea after each dose of Methacholine on a
BORG scale. It might be expected that forced
expiratory manoeuvres give a higher burden to the
patient as compared to the FOT-measurements. So,
another aim of the study was to evaluate the BORG-scores, to monitor the potential differences in
patient’s dyspnoea between the two methods. It
was hypothesised that the FOTwill have advantages
especially in patients who cannot or will not
cooperate and furthermore will lower the burden
to the patient, because the possibility to measure
airway hyperresponsiveness with less effort, lower
degree of brochoconstriction and less symptoms.
The reproducibility of the tests was also measured.Methods
Twenty asthmatics according to ERS criteria,
participated in the study. All subjects were
bronchial hyperresponsive to Methacholine bromide
(PC20_FEV1 o9.8mg/ml).6 They were in a stable
condition (FEV1 between the visits within 10%) and
their medication was not changed during the study.
Exclusion criteria were: other pulmonary dis-
eases, a history of thoracic-surgery, recent pneu-
mothorax, lactating or pregnant women, cardiac
diseases, use of b-blockers or oral corticosteroids,
FEV1 before bronchodilation o50%pr or o1.5 l and
inadequacy to understand instructions.
The patients signed an informed consent form
and the hospital ethics committee approved the
study.
Study design
On two different study days, the patients were
challenged with Methacholine bromide. All visits
were at the same time of the day with an interval
of at least 4 and at most 6 weeks.
Measurements
Long acting b2-agonists were discontinued at least
24 h and other pulmonary medication X8 h prior to
the visit. Caffeinated beverages and smoking were
stopped at least 2 h before the measurement.
Airway resistance was measured with FOT (Ran-
dom Noise Oscillator, SensorMedics, Bilthoven, The
Netherlands). The oscillatory resistance at 6Hz
(Rrs6) was used as outcome variable.
A flow–volume curve was performed with an
integrating pneumotachograph (SensorMedics,
Bilthoven, The Netherlands). Maximal in- and
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measured with a micro-mouth pressure meter
(MicroMedical Ltd., UK) from residual volume and
total lung capacity, respectively.
A Methacholine provocation test was performed
from NaCl 0.9% and subsequently from the starting
dose 0.038mg/ml with doubling doses up to
78.5mg/ml Methacholine bromide. After each
dose, patients scored their perception of dyspnoea
on a BORG scale. MIP and MEP were measured again
at the end of the test.Tabel 1 Patient characteristics.
Patient characteristics Mean (SD)
Gender (male/female) 14/6
Age (yrs) 48.3 (15.2)
FEV1 (l) 3.2 (0.9)
FEV1%pr 93 (18)
Rrs6 (cm H2O/l/s) 3.3 (1.1)
MIP%pr 88 (35)
Smoking (non/ex/current) 9/8/3
DPI/pMDI/spacer 11/4/5
FEV1: forced expiratory volume in 1 s; FEV1%pr: FEV1 as
percentage of predicted; Rrs6: airway resistance at 6Hz;
MIP: maximum inspiratory mouth pressure as percentage
of predicted; DPI: dry powder inhaler; pMDI: pressurized
metered dose inhaler.Methacholine provocation test
The bronchial provocation test with Methacholine
bromide was performed to assess the bronchial
hyperresponsiveness by the method described by
Juniper et al.6 Methacholine aerosol was generated
with DeVilbiss nebulizer (output 0.125ml/min)
(DeVilbiss, Somerset, MA, USA). Subjects initially
performed FOT- and flow–volume curves until three
reproducible curves were obtained (baselinepara-
meters). NaCl 0.9% was inhaled for 2min during
tidal breathing. 30 s later Rrs6 (three reproducible
curves) and FEV1 (single flow–volume maneuver)
were measured. These measurements were re-
peated after 90 s. Since, deep inspirations neces-
sary for flow–volume manoeuvres may influence the
bronchial tone, the FEV1 was systematically mea-
sured after the Rrs6. Subsequently, doubling con-
centrations from 0.038 to 78.5mg Methacholine
bromide/ml were inhaled during 2min tidal breath-
ing periods at a 5min interval. Since, the molecular
weight of Methacholine bromide is 20% higher than
Methacholine chloride as used by Juniper et al.6 the
concentrations used (0.038–78.5mg/ml) corre-
spond to the Methacholine chloride concentrations
of 0.031–64mg/ml. The test was continued until
there was a 20% or greater fall in FEV1 or until the
maximal Methacholine concentration of 78.5mg/ml
was reached. The percentage fall was calculated by
½FEV1baseline  ½post-Methacholine FEV1
½FEV1baseline
 100
PC20_FEV1 is the provocation concentration of
Methacholine that induces a 20% fall in FEV1 and
was assessed by interpolation on a log–dose
response curve.
The percentage increase of Rrs6 was calculated
by
½post-Methacholine Rrs6  ½Rrs6baseline
½Rrs6baseline  100
PC40_Rrs6 is the provocation concentration of
Methacholine that induces a 40% increase in Rrs6and was assessed by interpolation on a log–dose
response curve.
The FEV1 had to be within 10% of the FEV1_base-
line before the patient left the hospital. Broncho-
dilators were administered if the FEV1 was not
recovered spontaneously.
Statistical analysis
The primary study objective was the comparison of
PC20_FEV1 and PC40_Rrs6 (after logarithmic trans-
formation (base 2)), MIP and MEP before and after
bronchoprovocation and the perception of dys-
pnoea (BORG-scores) when PC20_FEV1 and
PC40_Rrs6 were reached. For these evaluations
repeated measurements analysis of variance using
SAS PROC MIXED (version 6.12 for Windows) was
used. This statistical program was also used to
evaluate the relationship between PC20_FEV1 and
PC40_Rrs6, while taking the inter- and intra-
individual differences into account using random-
coefficients models. Data were expressed as mean
7 SEM or as otherwise indicated. A two-sided P-
value of 0.05 was considered the limit of signifi-
cance.Results
Patient characteristics
Twenty asthma patients completed the study. Table
1 shows the patient characteristics. Baseline para-
meters at the different study-days did not differ
significantly ((mean (SD)) measurement 1 vs. mea-
surement 2: FEV1 3.2 (0.9) vs. 3.1 (0.9) l (P ¼ 0:08),
PEF 8.1 (1.8) vs. 7.9 (1.9) l/s (P ¼ 0:5) l/s and Rrs6
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procedures were well tolerated and no adverse
events were reported.Figure 2 The BORG-score PC20_FEV1 (&) and the mean
BORG-score at PC40_Rrs6 (K) during Methacholine
provocation test. BORG PC20_FEV1 was significantly
higher as compared to BORG PC40_Rrs6 (#Po0.05).PC20_FEV1 vs. PC40_Rrs6
Fig. 1 shows the geometric mean (SEM) PC20_FEV1
and PC40_Rrs6 obtained at both visits. The
PC20_FEV1-values were 2.2 (0.4) doubling dose
higher as compared to the PC40_Rrs6 (Po0.001).
This was not significant between the visits.
At the first visit, when FEV1 was decreased
by 20% from baseline (PC20_FEV1), the Rrs6 was
increased from 3.3 (1.1) to 5.2 (0.08) cm H2O/l/s.
The second visit, the Rrs6 was increased from 3.1
(0.9) to 5.0 (0.08) cm H2O/l/s, when PC20_FEV1
was reached. Data were expressed as geometric
mean (SEM).
The PC20_FEV1 and PC40_Rrs6 were significantly
correlated. There was an average increase of 0.78
(0.18) doubling dose PC40_Rrs6 per doubling dose
PC20_FEV1 (Po0.001).BORG PC20_FEV1 vs BORG PC40_Rrs6
Fig. 2 shows the BORG-scores obtained after the
final dose of Methacholine (BORG PC20_FEV1) and
the BORG-score obtained after the dose when the
PC40_Rrs6 was reached. The mean BORG PC40_Rrs6
was significantly lower as compared to the mean
(SD) BORG PC20_FEV1 (1.7 (0.2) BORG-levels)
(Po0.001).Figure 1 Geometric means (SEM) of PC20_FEV1 (&) and of
PC40_Rrs6 (K) during Methacholine provocation test.
PC20_FEV1 was significantly higher as compared to
PC40_Rrs6 (#Po0.001).Reproducibility of PC20_FEV1 and PC40_Rrs6
To measure the reproducibility of the PC20_FEV1
and PC40_Rrs6, both measurements were com-
pared. Fig. 3 shows the Bland Altman plots of
PC20_FEV1 and PC40_Rrs6. The mean (SD) differ-
ence between the PC20_FEV1 of measurement 1
and measurement 2 is 0.1 (1.4) doubling doses.
The mean (SD) difference of PC40_Rrs6 between
measurements 1 and 2 is 0.3 (2.7) doubling doses.Changes in respiratory muscle strength
Before and after each challenge test the maximal
in- and expiratory mouth pressure (MIP and MEP)
were measured. The mean MIP after the Methacho-
line provocation test was 1.0 (0.2) kPa lower as
compared to the mean MIP-value before the
challenge test (Po0.001). Also the mean MEP-
value was 0.7 (0.4) kPa lower after bronchoprovo-
cation (P ¼ 0:12).Discussion
In this study, the values of PC20_FEV1 and of
PC40_Rrs6, which are variables to indicate air-
way hyperresponsiveness, were compared. The
PC20_FEV1 was obtained by measuring flow–volume
manoeuvres after each provocative dose. The
PC40_Rrs6 was measured by the FOT.
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Figure 3 Bland-Altman plots for PC20_FEV1 of measurement 1 and 2 and PC40_Rrs6 of measurements 1 and 2. The data
are logarithmically transformed.
M.E.A.C. Broeders et al.1050PC20_FEV1 and PC40_Rrs6 were significantly
correlated. Per doubling dose PC20_FEV1 there
was an increase of 0.8 doubling dose PC40_Rrs6.
The FOT gave significantly lower threshold values
for determining bronchial hyperresponsiveness and
significantly less dyspnoea. Similar results were
found by Weersink et al. and Vink et al.7,8 So,
measuring PC40_Rrs6 as an indicator of bronchial
hyperresponsiveness may shorten the challenge
test and lowers the concentrations of bronchocon-
strictor agents that are needed. It must be noted
that there are validated guidelines for shortening
the conventional Methacholine challenge test
(PC20_FEV1) by starting at higher concentrations
and by eliminating concentrations. So, the gain in
time by measuring the PC40_Rrs6 will be of limited
value. However, the lower concentrations ofMethacholine during the ‘PC40_Rrs6 test will make
the test more safe’. No dose steps have to be
omitted, so the accuracy of finding the PC40_Rrs6
will be greater. Furthermore, only passive co-
operation of the patient and no special breathing
manoeuvres are required. The significantly lower
dyspnoea score on the BORG-scale, when the
PC40_Rrs6 was reached, indicated that a broncho-
provocation test assessed by measuring Rrs6, was
less strenuous for patients as compared to measur-
ing the PC20_FEV1.
The Bland-Altman plots showed that the mean
difference between the measurements on day 1
and 2 was low (0.1 doubling dose for PC20_FEV1
and 0.3 doubling dose for PC40_Rrs6). The
reproducibility of PC20_FEV1 was in accordance
with other authors. Trigg et al. studied the daily
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Methacholine by measuring PC20_FEV1 in adult
asthmatics and found a 95% prediction interval of
72.36 doubling doses.9 Delacourt et al. reported a
95% prediction interval of 2.6 doubling doses in
wheezy infants (one month reproducibility).10 As
far as we know, there were no one month
reproducibility data of PC40_Rrs6. Our findings
suggest that measuring PC40_Rrs6 is a little more
prone to variation as compared to PC20_FEV1 to
assess the level of airway hyperresponsiveness.
Since, deep inspirations, necessary for flow–volume
manoeuvres may influence the bronchial tone,
the FEV1 was systematically measured after the
Rrs6. It is not plausible that the fixed sequence of
the measurements have influenced the differen-
ces between PC20_FEV1 and PC40_Rrs6. A reduced
effect of Methacholine was not expected, since
the time span between the measurements was
very short (less than 1min). Some studies showed
that deep inspirations necessary for the forced
expiratory manoeuvres, modulate the bronchodila-
tor response in healthy subjects, but slightly or
not in asthma patients.11–13 Other investiga-
tions suggest the opposite. Sundblad et al. stated
that the effect of deep inhalations did not
discriminate between asthmatic and non-asthmatic
subjects.14 So, we concluded that discussion about
possible effects of deep inspirations on bronchial
patency can be avoided by assessing bronchial
hyperresponsiveness with the forced oscillation
technique.
It is likely that the FEV1 and Rrs6 reflect different
pathophysiological aspects of airflow obstruction.
Asthma patients with a stable FEV1 are also defined
as clinically stable patients. Possibly, the presence
of other pathophysiological aspects (e.g. small
airway inflammation) were not be found by the
conventional FEV1-response, but were correctly
detected by the Rrs6-response. The variation of
these masked factors may explain the poor repro-
ducibility of PC40_Rrs6 in ‘clinically stable’ asthma
patients being somewhat lower as compared to the
PC20_FEV1.
Furthermore, measuring airway hyperresponsive-
ness with the Methacholine challenge test suffers
from some overlap in the mild and borderline
hyperresponsive asthmatics and individuals who
have rhinitis but no lung diseases. Possibly, the
use of airway resistance might exaggerate this
overlap. Consequently, this may make the test
more sensitive, but reduces the specificity and
positive predictive value.
This study also investigated whether the respira-
tory muscles were susceptible to fatigue as a result
of the repeated forced manoeuvres. The MIPmeasured after the Methacholine provocation test
was significantly lower as compared to the MlP-
values before the test. Also the MEP-values tended
to be lower after the challenge test, however this
decrease was not significant (P ¼ 0:12). The ex-
piratory muscles are a larger muscle group, so they
are less prone to fatigue as compared to the
inspiratory muscles. Since, the inspiratory capacity
of our patients was significantly decreased after
the Methacholine induced bronchoconstriction
(data was not shown), strength and endurance of
the diaphragm can be impaired because of its
unfavourable position on the length tension curve
due to hyperinflation. It is unclear which part
of the MIP-decrease can be attributed to hyperin-
flation and which part to muscle fatigue as a result
of the repeated forced manoeuvres. However, it
can be concluded that the deterioration of the
respiratory muscle strength may influence the
performance of the flow–volume curves. The FOT-
measurements were performed during tidal breath-
ing, so these manoeuvres are independent of a
decrease in respiratory muscle strength. It is
conceivable that patients with deteriorated re-
spiratory muscles were less able to perform opti-
mal flow–volume curves. So, this fatigue would
lower PC20_FEV1 as compared to PC40_Rrs6.
Nevertheless, this hypothesis was not confirmed in
our study. Possibly, the effects of Methacholine
induced hyperinflation and fatigued respiratory
muscles were not of great importance on the
forced manoeuvres.
In conclusion, assessing the Methacholine bro-
mide induced bronchoconstriction by measuring
the respiratory impedance (PC40_Rrs6) shortens
the challenge test and lowers the concentrations
of bronchoconstrictor agents that are needed as
compared to measurements of the conventional
PC20_FEV1. The BORG-scores at PC40_Rrs6 were
significantly lower as compared to the BORG-
scores at PC20_FEV1, which indicates that the first
method was less strenuous for patients. FOT-
measurements need only passive cooperation. So,
there seemed to be no effects of the deteriorated
respiratory muscle strength. Unfortunately, the
reproducibility of this FOT-method is some-
what less than measuring PC20_FEV1. Since, the
measurement of FEV1 showed the best reproduci-
bility, and FEV1 is the most conventional diagnostic
lung function variable, it has been used as the
standard to measure airway obstruction. How-
ever, our observations show the value of the FOT
in the evaluation of induced bronchoconstriction,
especially in patients who cannot or will not
cooperate or with impaired respiratory muscle
function.
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